J. Audsley

发表

G. Tannock, J. Audsley, 2012, Drugs.

Integrated immune networks in SARS-CoV-2 infected pregnant women reveal differential NK cell and unconventional T cell activation

K. Subbarao, Thi H. O. Nguyen, K. Kedzierska, 2021, medRxiv.

The anti-HIV activity of entecavir: a multicentre evaluation of lamivudine-experienced and lamivudine-naive patients

R. Siliciano, S. Lewin, C. Thio, 2008, AIDS.

A gathering storm: HIV infection and nonalcoholic fatty liver disease in low and middle-income countries

N. Thomas, S. Lewin, N. Kapoor, 2019, AIDS.

SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity

David F. Boyd, Thi H. O. Nguyen, K. Kedzierska, 2022, Nature Communications.

The role of cell culture vaccines in the control of the next influenza pandemic

G. Tannock, J. Audsley, 2004, Expert opinion on biological therapy.

AIDS A gathering storm: HIV infection and non-alcoholic fatty liver disease (NAFLD) in low and middle-income countries (LMIC)

N. Thomas, S. Lewin, N. Kapoor, 2018 .

Effects of long-term tenofovir-based combination antiretroviral therapy in HIV-hepatitis B virus coinfection on persistent hepatitis B virus viremia and the role of hepatitis B virus quasispecies diversity

S. Lewin, F. Luciani, S. Bent, 2016, AIDS.

Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)‐coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations

S. Lewin, S. Locarnini, J. Sasadeusz, 2009, HIV medicine.

Intrahepatic CXCL10 is strongly associated with liver fibrosis in HIV-Hepatitis B co-infection

S. Lewin, P. Revill, J. Torresi, 2020, PLoS pathogens.

The growth of attenuated influenza vaccine donor strains in continuous cell lines.

G. Tannock, J. Audsley, 2005, Journal of virological methods.

Integrated immune dynamics define correlates of COVID-19 severity and antibody responses

Givanna H. Putri, S. Lewin, S. Kent, 2020, Cell Reports Medicine.

The effect of antiretroviral intensification with dolutegravir on residual virus replication in HIV-infected individuals: a randomised, placebo-controlled, double-blind trial.

S. Lewin, S. Kent, J. Elliott, 2018, The lancet. HIV.

Pathway and Network Analyses Identify Growth Factor Signaling and MMP9 as Potential Mediators of Mitochondrial Dysfunction in Severe COVID-19

K. Schughart, J. Iredell, K. R. Short, 2023, International journal of molecular sciences.

Alternative approaches in the preparation and growth of influenza B vaccine viruses

J. Audsley, 2007 .

HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing.

S. Lewin, K. Ruxrungtham, C. Thio, 2010, Virology.

Viral Adaptation to Host Immune Responses Occurs in Chronic Hepatitis B Virus (HBV) Infection, and Adaptation Is Greatest in HBV e Antigen-Negative Disease

I. James, S. Mallal, S. Lewin, 2011, Journal of Virology.

HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment

S. Lewin, J. Sasadeusz, A. Avihingsanon, 2017, AIDS.

HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy

Wei Zhao, S. Lewin, P. Revill, 2022, EBioMedicine.

Factors Associated with Elevated ALT in an International HIV/HBV Co-Infected Cohort on Long-Term HAART

S. Lewin, K. Ruxrungtham, C. Thio, 2011, PloS one.

infected individuals on long-term HBV-active cART

S. Lewin, J. Sasadeusz, G. Matthews, 2016 .

Long-Term TDF-Inclusive ART and Progressive Rates of HBsAg Loss in HIV-HBV Coinfection-Lessons for Functional HBV Cure?

S. Lewin, J. Sasadeusz, S. Bowden, 2020, Journal of acquired immune deficiency syndromes.

HIV replication is associated with increased severity of liver biopsy changes in HIV‐HBV and HIV‐HCV co‐infection

S. Lewin, Z. Goodman, J. Sasadeusz, 2012, Journal of medical virology.

Biomarkers of inflammation and coagulation are associated with mortality and hepatitis flares in persons coinfected with HIV and hepatitis viruses.

S. Lewin, K. Ruxrungtham, D. Boulware, 2013, The Journal of infectious diseases.

Liver Fibrosis Regression Measured by Transient Elastography in Human Immunodeficiency Virus (HIV)-Hepatitis B Virus (HBV)-Coinfected Individuals on Long-Term HBV-Active Combination Antiretroviral Therapy

S. Lewin, J. Sasadeusz, G. Matthews, 2016, Open forum infectious diseases.

Challenges and opportunities for hepatitis B cure in the setting of HIV-hepatitis B virus co-infection.

J. Sasadeusz, J. Audsley, 2020, Current opinion in HIV and AIDS.

Markers of Immune Activation and Inflammation Are Associated with Higher Levels of Genetically-Intact HIV in HIV-HBV Co-Infected Individuals

S. Lewin, T. Schlub, Wei Zhao, 2022, Journal of virology.

Therapeutics for COVID-19: established and in development

S. Lewin, J. Sasadeusz, J. Audsley, 2020 .

Medication adherence, condom use and sexually transmitted infections in Australian preexposure prophylaxis users

R. Grant, J. D. de Wit, M. Stoové, 2017, AIDS.

Medication adherence, condom use and sexually transmitted infections in Australian PrEP users: interim results from the Victorian PrEP Demonstration Project.

R. Grant, J. D. de Wit, M. Stoové, 2017, AIDS.

CXCL-10, Interleukin-12 and Interleukin-21 are not Immunological Predictors of Hbeag Seroconversion in HIV-1–HBV Coinfection following HBV-Active Antiretroviral Therapy

S. Lewin, K. Ruxrungtham, J. Sasadeusz, 2014, Antiviral therapy.

Cell-based influenza vaccines: progress to date.

G. Tannock, Jennifer M Audsley, Gregory A Tannock, 2008, Drugs.

Blood transcriptome responses in patients correlate with severity of COVID-19 disease

K. Schughart, J. Iredell, K. R. Short, 2023, Frontiers in Immunology.

Immune profiling of SARS-CoV-2 infection during pregnancy reveals NK cell and γδ T cell perturbations

M. Davenport, K. Subbarao, Thi H. O. Nguyen, 2023, JCI insight.

Temporal differences in culturable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) from the respiratory and gastrointestinal tracts in a patient with moderate coronavirus disease 2019 (COVID-19)

K. Subbarao, Thi H. O. Nguyen, K. Kedzierska, 2021, Infection Control & Hospital Epidemiology.

Temporal differences in culturable SARS-CoV-2 from the respiratory and gastro-intestinal tracts in a patient with moderate COVID-19.

K. Subbarao, Thi H. O. Nguyen, K. Kedzierska, 2021, Infection control and hospital epidemiology.

Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities

M. Davenport, K. Subbarao, J. Crawford, 2023, Nature Immunology.

Predictors of liver disease progression in people living with HIV-HBV co-infection on antiretroviral therapy

A. Avihingsanon, M. Crane, J. Audsley, 2024, EBioMedicine.